SIMPLY BETTER BRANDS CORP (SBBC.CA) Stock Fundamental Analysis

TSX-V:SBBC • CA82888R1055

0.86 CAD
-0.04 (-4.44%)
Last: Oct 3, 2025, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Taking everything into account, SBBC scores 3 out of 10 in our fundamental rating. SBBC was compared to 33 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of SBBC have multiple concerns. While showing a medium growth rate, SBBC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • SBBC had negative earnings in the past year.
  • In the past year SBBC had a positive cash flow from operations.
  • SBBC had negative earnings in each of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: SBBC reported negative operating cash flow in multiple years.
SBBC.CA Yearly Net Income VS EBIT VS OCF VS FCFSBBC.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

  • SBBC has a Return On Assets of -1.47%. This is in the better half of the industry: SBBC outperforms 61.76% of its industry peers.
  • Looking at the Return On Equity, with a value of -22.83%, SBBC is in line with its industry, outperforming 47.06% of the companies in the same industry.
Industry RankSector Rank
ROA -1.47%
ROE -22.83%
ROIC N/A
ROA(3y)-53.1%
ROA(5y)-47.26%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SBBC.CA Yearly ROA, ROE, ROICSBBC.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

  • SBBC's Gross Margin of 29.78% is in line compared to the rest of the industry. SBBC outperforms 50.00% of its industry peers.
  • SBBC's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for SBBC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.17%
GM growth 5YN/A
SBBC.CA Yearly Profit, Operating, Gross MarginsSBBC.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • SBBC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, SBBC has more shares outstanding
  • Compared to 5 years ago, SBBC has more shares outstanding
  • SBBC has a better debt/assets ratio than last year.
SBBC.CA Yearly Shares OutstandingSBBC.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
SBBC.CA Yearly Total Debt VS Total AssetsSBBC.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of -0.48, we must say that SBBC is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -0.48, SBBC perfoms like the industry average, outperforming 58.82% of the companies in the same industry.
  • SBBC has a debt to FCF ratio of 6.61. This is a slightly negative value and a sign of low solvency as SBBC would need 6.61 years to pay back of all of its debts.
  • SBBC has a Debt to FCF ratio of 6.61. This is in the better half of the industry: SBBC outperforms 79.41% of its industry peers.
  • A Debt/Equity ratio of 2.69 is on the high side and indicates that SBBC has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 2.69, SBBC is doing worse than 82.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.69
Debt/FCF 6.61
Altman-Z -0.48
ROIC/WACCN/A
WACC7.68%
SBBC.CA Yearly LT Debt VS Equity VS FCFSBBC.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

2.3 Liquidity

  • SBBC has a Current Ratio of 0.90. This is a bad value and indicates that SBBC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SBBC has a worse Current ratio (0.90) than 82.35% of its industry peers.
  • A Quick Ratio of 0.74 indicates that SBBC may have some problems paying its short term obligations.
  • SBBC has a Quick ratio of 0.74. This is in the lower half of the industry: SBBC underperforms 73.53% of its industry peers.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.74
SBBC.CA Yearly Current Assets VS Current LiabilitesSBBC.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 98.61% over the past year.
  • The Revenue for SBBC has decreased by -42.52% in the past year. This is quite bad
  • The Revenue has been growing by 42.58% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)98.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.93%
Revenue 1Y (TTM)-42.52%
Revenue growth 3Y42.58%
Revenue growth 5YN/A
Sales Q2Q%3.75%

3.2 Future

  • SBBC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.10% yearly.
  • SBBC is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 35.80% yearly.
EPS Next Y0%
EPS Next 2Y29.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year41.19%
Revenue Next 2Y35.8%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SBBC.CA Yearly Revenue VS EstimatesSBBC.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
SBBC.CA Yearly EPS VS EstimatesSBBC.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -0.05 -0.1 -0.15

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • SBBC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SBBC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SBBC.CA Price Earnings VS Forward Price EarningsSBBC.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, SBBC is valued a bit cheaper than 64.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 58.09
EV/EBITDA N/A
SBBC.CA Per share dataSBBC.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as SBBC's earnings are expected to grow with 29.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.1%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for SBBC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

SIMPLY BETTER BRANDS CORP

TSX-V:SBBC (10/3/2025, 7:00:00 PM)

0.86

-0.04 (-4.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)06-02
Earnings (Next)08-25
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap92.54M
Revenue(TTM)45.90M
Net Income(TTM)-377.00K
Analysts84
Price Target2.3 (167.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-200%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.44
P/FCF 58.09
P/OCF 57.09
P/B 39.98
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)0.01
FCFY1.72%
OCF(TTM)0.02
OCFY1.75%
SpS0.6
BVpS0.02
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.47%
ROE -22.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.78%
FCFM 2.48%
ROA(3y)-53.1%
ROA(5y)-47.26%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.17%
GM growth 5YN/A
F-Score5
Asset Turnover1.79
Health
Industry RankSector Rank
Debt/Equity 2.69
Debt/FCF 6.61
Debt/EBITDA N/A
Cap/Depr 1.3%
Cap/Sales 0.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.9
Quick Ratio 0.74
Altman-Z -0.48
F-Score5
WACC7.68%
ROIC/WACCN/A
Cap/Depr(3y)2.76%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.18%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.93%
EPS Next Y0%
EPS Next 2Y29.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-42.52%
Revenue growth 3Y42.58%
Revenue growth 5YN/A
Sales Q2Q%3.75%
Revenue Next Year41.19%
Revenue Next 2Y35.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y73.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year271.48%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y133.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y134.46%
OCF growth 3YN/A
OCF growth 5YN/A

SIMPLY BETTER BRANDS CORP / SBBC.CA FAQ

What is the ChartMill fundamental rating of SIMPLY BETTER BRANDS CORP (SBBC.CA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to SBBC.CA.


What is the valuation status of SIMPLY BETTER BRANDS CORP (SBBC.CA) stock?

ChartMill assigns a valuation rating of 2 / 10 to SIMPLY BETTER BRANDS CORP (SBBC.CA). This can be considered as Overvalued.


How profitable is SIMPLY BETTER BRANDS CORP (SBBC.CA) stock?

SIMPLY BETTER BRANDS CORP (SBBC.CA) has a profitability rating of 2 / 10.


What is the earnings growth outlook for SIMPLY BETTER BRANDS CORP?

The Earnings per Share (EPS) of SIMPLY BETTER BRANDS CORP (SBBC.CA) is expected to decline by 0% in the next year.


Is the dividend of SIMPLY BETTER BRANDS CORP sustainable?

The dividend rating of SIMPLY BETTER BRANDS CORP (SBBC.CA) is 0 / 10 and the dividend payout ratio is 0%.